| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | LQDA Liquidia Corp | Singh Raman | Director | Sell | 7,500 | $29.42 | $220,650.00 | -19.4% | +5.4% | - | |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 15,091 | $35.50 | $535,730.50 | -25.3% | +12.9% | - | |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Megna Michael R | Chief Accounting Officer | Sell | 11,000 | $34.84 | $383,240.00 | -22.4% | +12.9% | - | |
| Sep 2, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $417.64 | $9,396,837.06 | -32.8% | +18.6% | - | |
| Sep 2, 2025 | BMY Bristol Myers Squibb Co | Elkins David V | EVP, Chief Financial Officer | Sell | 56,000 | $47.33 | $2,650,480.00 | -25.1% | +3.7% | - | |
| Sep 2, 2025 | CWBHF Charlotte's Web Holdings, Inc. | Kunkel Raymond J. | Chief Operating Officer | Buy | 229,167 | $0.10 | $22,916.70 | +46.8% | - | - | |
| Sep 2, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $30.98 | $15,491.65 | -0.6% | -10.9% | - | |
| Sep 2, 2025 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 3,000 | $423.21 | $1,269,630.00 | -14.6% | +18.6% | - | |
| Sep 2, 2025 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 70,692 | $28.63 | $2,023,670.60 | -10.6% | +12.1% | - | |
| Sep 2, 2025 | LQDA Liquidia Corp | Kaseta Michael58 | CFO And COO | Sell | 1,148 | $29.05 | $33,349.40 | -0.3% | +12.1% | - | |
| Sep 2, 2025 | PLNH Planet 13 Holdings Inc. | Groesbeck Robert | Co-ceo | Sell | 318,000 | $0.29 | $91,758.90 | -2.8% | - | - | |
| Sep 2, 2025 | LQDA Liquidia Corp | Schundler Russell59 | General Counsel | Sell | 1,063 | $29.05 | $30,880.15 | -0.2% | +12.1% | - | |
| Sep 2, 2025 | LQDA Liquidia Corp | Manning Paul B54 | Director | Sell | 670,837 | $28.26 | $18,957,475.28 | -20.2% | +12.1% | - | |
| Sep 2, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 26,508 | $27.88 | $738,955.76 | -7.2% | +12.1% | - | |
| Aug 29, 2025 | LQDA Liquidia Corp | Krepp Sarah | Chief Human Resource Officer | Sell | 209 | $29.05 | $6,071.45 | -0.1% | +17.9% | - | |
| Aug 29, 2025 | COLL Collegium Pharmaceutical, Inc | Smith Thomas B60 | EVP And Chief Medical Officer | Sell | 17,478 | $38.42 | $671,576.42 | -19.9% | +20.3% | - | |
| Aug 29, 2025 | LQDA Liquidia Corp | Boyle Dana | Chief Accounting Officer | Sell | 296 | $29.05 | $8,598.80 | -0.2% | +17.9% | - | |
| Aug 29, 2025 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 121 | $3.29 | $397.89 | - | -35.2% | - | |
| Aug 29, 2025 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 262 | $3.29 | $861.57 | - | -35.2% | - | |
| Aug 29, 2025 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 262 | $3.29 | $861.57 | - | -35.2% | - | |
| Aug 29, 2025 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 1,372 | $3.29 | $4,516.28 | - | -35.2% | - | |
| Aug 28, 2025 | LLY Eli Lilly & Co | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 1,000 | $734.93 | $734,930.00 | -20.7% | +50.9% | - | |
| Aug 28, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 20,000 | $27.85 | $557,072.00 | -7.4% | +15.5% | - | |
| Aug 28, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 34,800 | $45.10 | $1,569,430.50 | -1.6% | +2.0% | - | |
| Aug 28, 2025 | PLNH Planet 13 Holdings Inc. | Groesbeck Robert | Co-ceo | Sell | 478,000 | $0.29 | $139,943.60 | -3.8% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.